Nuwellis Inc. to Speak at Upcoming Investor Conferences
H.C. Wainwright 23rd AnnualGlobal Investment Conference , a virtual event with Nuwellis’ presentation scheduled forMonday, September 13, 2021 at7:00 AM Eastern Time Lake Street Capital Markets 5th AnnualBest Ideas Growth Conference , an invitation-only event, featuring over 100 dynamic, small-cap companies interacting with top institutional investors. A Fireside Chat withNuwellis is scheduled forTuesday, September 14, 2021 , at11:00 AM Eastern Time
About
About the Aquadex SmartFlow System
The Aquadex SmartFlow system delivers clinically proven therapy using a simple, flexible and smart method of removing excess fluid from patients suffering from hypervolemia (fluid overload). The Aquadex SmartFlow system is indicated for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kg or more whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered by a health care provider, within an outpatient or inpatient clinical setting, under physician prescription, both having received training in extracorporeal therapies.
CONTACTS
INVESTORS:
Chief Financial Officer
ir@nuwellis.com
Matt.bacso@gilmartinir.com
MEDIA:
Health+Commerce
260-336-6202
jstebing@healthandcommerce.com
Source: Nuwellis, Inc.